Records containing: Solid Organ Transplant Complications

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-04-27
  An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)
• CLINICAL_TRIALS study record update · 2026-02-20
  An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)
• CLINICAL_TRIALS study record update · 2026-02-20
  Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy
• CLINICAL_TRIALS study record update · 2025-05-30
  A Phase I, Single-Center, Open-Label Trial to Assess the Safety and Tolerability of Delayed Infusion of a Naïve T Cell Depleted Hematopoietic Graft and Memory T-lymphocytes in Recipients of Solid Organ Transplantation
• CLINICAL_TRIALS study record update · 2024-12-12
  Washed Microbiota Transplantation for Postoperative Complications in Solid Organ Transplantation
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2024-11-27
  Washed Microbiota Transplantation for Postoperative Complications in Solid Organ Transplantation
• CLINICAL_TRIALS study record update · 2023-06-15
  Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There Are No Appropriate Alternative Therapies